KKR & Co. Inc. (NYSE:KKR) Price Target Raised to $162.00 at Keefe, Bruyette & Woods

Key Points

• Keefe, Bruyette & Woods has raised its price target for KKR & Co. Inc. from $155.00 to $162.00, indicating a potential upside of 11.68% from the current price.
• KKR's stock currently has an average rating of "Moderate Buy" among analysts, with a consensus price target of $157.73.
• Major shareholder Genetic Disorder L.P. KKR sold 6 million shares of the company, representing a significant decrease in their ownership.

KKR & Co. Inc. (NYSE:KKR - Get Free Report) had its price objective increased by Keefe, Bruyette & Woods from $155.00 to $162.00 in a report released on Monday,Benzinga reports. The firm currently has an "outperform" rating on the asset manager's stock. Keefe, Bruyette & Woods' price objective would indicate a potential upside of 11.68% from the company's current price.

KKR has been the topic of several other reports. Wall Street Zen upgraded shares of KKR & Co. Inc. from a "strong sell" rating to a "hold" rating in a research report on Saturday. Wells Fargo & Company upped their price target on shares of KKR & Co. Inc. from $140.00 to $156.00 and gave the company an "overweight" rating in a report on Friday, July 11th. TD Cowen cut their price target on shares of KKR & Co. Inc. from $183.00 to $126.00 and set a "buy" rating on the stock in a report on Wednesday, April 9th. Citigroup upped their price target on shares of KKR & Co. Inc. from $160.00 to $170.00 and gave the company a "buy" rating in a report on Friday. Finally, JMP Securities restated a "market perform" rating and issued a $150.00 target price on shares of KKR & Co. Inc. in a research note on Monday, July 14th. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $157.73.

KKR & Co. Inc. Stock Performance

NYSE:KKR traded up $2.50 during trading hours on Monday, reaching $145.05. The company had a trading volume of 1,609,441 shares, compared to its average volume of 4,998,898. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.77. KKR & Co. Inc. has a 52 week low of $86.15 and a 52 week high of $170.40. The firm has a market cap of $129.19 billion, a price-to-earnings ratio of 67.49, a PEG ratio of 1.59 and a beta of 1.87. The firm's 50 day moving average price is $133.14 and its 200-day moving average price is $128.11.

KKR & Co. Inc. (NYSE:KKR - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The asset manager reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.81 billion. KKR & Co. Inc. had a net margin of 12.95% and a return on equity of 6.42%. During the same quarter in the previous year, the firm posted $1.09 EPS. On average, analysts forecast that KKR & Co. Inc. will post 5.19 EPS for the current year.

Insider Buying and Selling

In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the firm's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $34.20, for a total value of $205,200,000.00. Following the completion of the sale, the insider owned 13,260,971 shares in the company, valued at approximately $453,525,208.20. This trade represents a 31.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Scully acquired 13,250 shares of KKR & Co. Inc. stock in a transaction that occurred on Tuesday, May 6th. The stock was bought at an average price of $113.49 per share, with a total value of $1,503,742.50. Following the purchase, the director directly owned 13,250 shares of the company's stock, valued at approximately $1,503,742.50. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have sold 8,471,488 shares of company stock worth $501,529,092. 39.34% of the stock is currently owned by insiders.

Institutional Investors Weigh In On KKR & Co. Inc.

A number of institutional investors have recently bought and sold shares of KKR. Brighton Jones LLC lifted its position in shares of KKR & Co. Inc. by 109.6% during the fourth quarter. Brighton Jones LLC now owns 4,661 shares of the asset manager's stock worth $689,000 after purchasing an additional 2,437 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in KKR & Co. Inc. by 104.7% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 56,423 shares of the asset manager's stock valued at $8,346,000 after acquiring an additional 28,862 shares during the last quarter. Pitcairn Co. lifted its position in shares of KKR & Co. Inc. by 19.4% in the 4th quarter. Pitcairn Co. now owns 1,976 shares of the asset manager's stock valued at $292,000 after acquiring an additional 321 shares in the last quarter. Dynamic Technology Lab Private Ltd lifted its position in shares of KKR & Co. Inc. by 151.0% in the fourth quarter. Dynamic Technology Lab Private Ltd now owns 5,570 shares of the asset manager's stock worth $824,000 after purchasing an additional 3,351 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its holdings in KKR & Co. Inc. by 8.4% in the fourth quarter. Envestnet Asset Management Inc. now owns 1,336,716 shares of the asset manager's stock worth $197,714,000 after buying an additional 103,924 shares during the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

KKR & Co. Inc. Company Profile

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm's business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.